The Center for Genomics and Oncological Research (GENyO)
GENyO expands analytic capacity for precision medicine
At a glance
GENyO expands analytic capacity to accelerate strategically important research that can help pharma companies create new treatments and support the Andalusian Department of Health’s drive to bring precision medicine to the region’s 9 million citizens.
Outcomes
Researchers enjoy increased performance, scalability, and reliability. They have the flexibility to run diverse projects, including many that involve sophisticated analysis of heterogeneous data sets.
This finer-grained diagnostic capability can help pharma companies choose the best treatments for each patient and develop new treatments, and it is particularly valuable for people suffering from less common difficult-to-diagnose autoimmune diseases. The progress in this area is tremendously exciting.
Marta Alarcón Riquelme,
Scientific Director Genomic Unit and Medical Genomics Department, GENyO
A growing need for advanced analytics
A multidisciplinary research institute focused on the genetic basis of human diseases, GENyO needs scalable, high-performance computing resources to turn clinical and genomic data into scientific insights that ultimately improve human health. Its small cluster and individual workstations were swamped by growing demand.
Atos solution
GENyO deployed an Atos BullSequana X blade system, with each node powered by Intel® Xeon® processor. The system provides over 11 teraflops of computing power and 2.25 terabytes of RAM.
The solution has been deployed under the umbrella of the Atos HPC, AI and Quantum Life Sciences Center of Excellence (LSCoE), the realization of Atos global strategy to bring advanced computing technologies closer to life sciences projects with the goal of discovering fresh, innovative solutions.
Outcomes
- Researchers enjoy increased performance, scalability, and reliability. They have the flexibility to run diverse projects, including many that involve sophisticated analysis of heterogeneous data sets.
- GENyO accelerates strategically important research that can help pharma companies create new treatments and support the Andalusian Department of Health’s drive to bring precision medicine to the region’s 9 million citizens.
- With compact, energy-efficient technologies from Intel and Atos, GENyO reduces power consumption and frees floor and rack space, supporting future growth requirements.
- Solution delivered through the Atos Life Sciences Center of Excellence (LSCoE) that provides access to experts in advanced computing technologies.
Our Experts
Natalia Jiménez Lozano
Head of Atos Life Science Center of Excellence
Related resources
Blog
Technological advances to prevent skin cancer
Skin cancer accounts for one in every three cancers diagnosed. Fortunately, technological advances are helping to fight the disease.
Thought leadership
Journey 2024 in healthcare and life sciences
Healthcare organizations face complex challenges to meet the demands of growing and aging populations, together with rises in long-term health conditions and the needs of the pandemic response.
Client story
CNAG- Sequencing and Supercomputers
From Data to Discoveries, Atos helps to drive new health insights faster.
On-demand webinar
Leap your life sciences project to the “quantum” level
Atos quantum experts will walk you through some obvious life sciences quantum use cases and inspire you to think of other relevant applications.
Research
Bringing to life unimaginable
Quantum, high performance computing (HPC) as well as edge computing assisted by artificial intelligence hold exciting, transformative potential for the life sciences sector.
Solutions
HPC, AI & Quantum Life Sciences Center of Excellence
New technologies such as high-performance computing (HPC), quantum computing (QC) and artificial intelligence (AI) have the potential to bring about game changing results in genomics and biodata.